Maas J W, Koslow S H, Katz M M, Bowden C L, Gibbons R L, Stokes P E, Robins E, Davis J M
Am J Psychiatry. 1984 Oct;141(10):1159-71. doi: 10.1176/ajp.141.10.1159.
Relationships between pretreatment neurotransmitter metabolite levels and response to imipramine and amitriptyline were studied in 104 depressed patients. Normal values for urinary norepinephrine and low values for urinary MHPG were associated with greater incidence of drug response in bipolar, but not unipolar, patients. For unipolar, but not bipolar, patients low CSF 5-HIAA and high urinary metanephrine values were associated with a greater incidence of drug response. These data indicate that the pretreatment functional state of catecholamine and serotonin systems is associated with type of response to drug treatment. The authors present hypotheses about the association of alterations in serotonin and norepinephrine systems and definable subtypes of depression.
在104例抑郁症患者中研究了治疗前神经递质代谢产物水平与对丙咪嗪和阿米替林反应之间的关系。尿去甲肾上腺素正常值和尿3-甲氧基-4-羟基苯乙二醇(MHPG)低值与双相情感障碍患者(而非单相抑郁症患者)更高的药物反应发生率相关。对于单相抑郁症患者(而非双相情感障碍患者),脑脊液5-羟吲哚乙酸(5-HIAA)低值和尿间甲肾上腺素高值与更高的药物反应发生率相关。这些数据表明,儿茶酚胺和5-羟色胺系统的治疗前功能状态与药物治疗反应类型相关。作者提出了关于5-羟色胺和去甲肾上腺素系统改变与可定义的抑郁症亚型之间关联的假说。